Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The 5-hydroxytryptamine receptor 3A subunit (5-HT3A) is a protein that, together with other 5-HT3 subunits, forms the functional 5-HT3 receptor, a ligand-gated cation-selective ion channel of the Cys-loop superfamily. It uniquely mediates fast excitatory neurotransmission by opening in response to serotonin (5-HT) binding, allowing the rapid influx of sodium, potassium, and to some extent calcium ions through the cell membrane, ultimately leading to neuronal depolarization. The 5-HT3A subunit is essential for receptor function: either as a homopentamer (five 5-HT3A subunits) or as the required component in heteropentameric complexes with other related subunits (5-HT3B, C, D, or E). Pharmacologically, the 5-HT3 receptor is notable as the target of several potent antiemetic drugs (“setrons,” such as ondansetron) used to treat nausea and vomiting, especially in cancer and post-surgical patients. It is uniquely not a G-protein coupled receptor (unlike most serotonin receptor subtypes), but rather directly forms an ion channel. Its function and pharmacology are further influenced by alternative subunit composition, post-translational modification (e.g., glycosylation), and interaction with intracellular proteins. Overall, the 5-HT3A subunit is central both to basic neurotransmission and to drug action in the nervous and gastrointestinal systems.
Competitive antagonism at the 5-HT3 (ligand-binding) site; Blockade of serotonin-induced opening of the ion channel, inhibiting depolarization and neuronal firing
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5-hydroxytryptamine receptor 3A subunit (5-HT3A).